IRIS
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.925
NA - Nord America 7.735
EU - Europa 1.835
SA - Sud America 1.475
AF - Africa 153
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.149
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.546
SG - Singapore 5.046
CN - Cina 1.289
BR - Brasile 1.227
VN - Vietnam 701
IE - Irlanda 343
IT - Italia 317
FI - Finlandia 276
DE - Germania 271
HK - Hong Kong 238
GB - Regno Unito 167
IN - India 147
AR - Argentina 103
BD - Bangladesh 86
CA - Canada 74
RU - Federazione Russa 73
FR - Francia 71
MX - Messico 71
IQ - Iraq 66
SE - Svezia 54
PL - Polonia 51
ES - Italia 48
EC - Ecuador 47
TR - Turchia 43
ID - Indonesia 42
JP - Giappone 42
ZA - Sudafrica 40
PH - Filippine 31
PK - Pakistan 30
NL - Olanda 28
CZ - Repubblica Ceca 27
UA - Ucraina 25
SA - Arabia Saudita 23
CO - Colombia 21
MA - Marocco 21
AU - Australia 20
NG - Nigeria 20
UZ - Uzbekistan 20
EG - Egitto 19
PE - Perù 17
VE - Venezuela 17
LT - Lituania 15
JO - Giordania 13
KE - Kenya 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
MY - Malesia 12
TN - Tunisia 12
DO - Repubblica Dominicana 11
AZ - Azerbaigian 10
IL - Israele 10
NP - Nepal 10
PT - Portogallo 10
PY - Paraguay 9
AT - Austria 7
BO - Bolivia 7
DZ - Algeria 7
AL - Albania 6
BH - Bahrain 6
ET - Etiopia 6
HN - Honduras 6
OM - Oman 6
AO - Angola 5
CR - Costa Rica 5
HU - Ungheria 5
KG - Kirghizistan 5
KZ - Kazakistan 5
PA - Panama 5
BY - Bielorussia 4
KR - Corea 4
NI - Nicaragua 4
PS - Palestinian Territory 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
BE - Belgio 3
BG - Bulgaria 3
GE - Georgia 3
GR - Grecia 3
JM - Giamaica 3
KW - Kuwait 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DM - Dominica 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
NO - Norvegia 2
PR - Porto Rico 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
Totale 19.127
Salva come PNG Salva come JPEG
Città #
Singapore 2.071
Ashburn 1.573
Dallas 1.314
San Jose 1.072
The Dalles 828
Shanghai 693
Boardman 463
New York 428
Dublin 341
Helsinki 275
Beijing 234
Hong Kong 226
Ho Chi Minh City 224
Los Angeles 193
Hanoi 159
Falkenstein 123
São Paulo 103
Seattle 84
Santa Clara 82
London 60
Phoenix 54
Assago 50
Da Nang 50
Chandler 49
Naples 48
Milan 47
Warsaw 47
Orem 44
Moscow 42
Chennai 38
Rio de Janeiro 38
Montreal 34
Brooklyn 32
Tokyo 32
Council Bluffs 31
Johannesburg 30
Chicago 28
Brasília 27
Dhaka 26
Haiphong 25
Curitiba 24
Atlanta 23
Belo Horizonte 23
Boston 23
Stockholm 22
Baghdad 21
Wilmington 21
Frankfurt am Main 20
Denver 19
Manchester 19
San Francisco 19
Benin City 18
Tashkent 18
Brno 17
Guayaquil 17
Mexico City 17
Sydney 16
Ankara 15
Pune 15
Campinas 14
Guarulhos 14
Munich 14
Buffalo 13
Hangzhou 13
Houston 13
Quito 13
Rome 13
Erbil 12
Fortaleza 12
Nairobi 12
Salvador 12
Amsterdam 11
Lima 11
Montevideo 11
Ninh Bình 11
Porto Alegre 11
Santo André 11
Shijiazhuang 11
Thái Bình 11
Amman 10
Baku 10
Biên Hòa 10
Charlotte 10
Lawrence 10
Mumbai 10
Praia Grande 10
Princeton 10
Ribeirão Preto 10
Toronto 10
Buenos Aires 9
Cairo 9
Hillsboro 9
Hải Dương 9
Maceió 9
Paris 9
Reston 9
Santiago 9
Goiânia 8
Istanbul 8
Joinville 8
Totale 12.124
Salva come PNG Salva come JPEG
Nome #
100 years of respiratory medicine : Pneumonia 639
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 376
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 128
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 112
COVID-19 in Immunocompromised Patients: A Systematic Review 105
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia 101
Community-acquired pneumonia 88
Mapping the human genetic architecture of COVID-19 88
Cardiovascular Complications in Community-Acquired Pneumonia 84
A 13-year-old female with shortness of breath and pleuritic chest pain 84
A pathway to keep all lifelong learners up to date: The ERS continuing professional development programme 83
A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis 79
COVID-19 in lung transplant recipients: A case series from Milan, Italy 78
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 77
Quando ospedalizzare un paziente con polmonite acquisita in comunità 77
Diagnosis and Initial Investigation of Bronchiectasis 74
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 72
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 72
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE 71
A 61-year-old female with chronic cough and purulent sputum 71
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 71
A comprehensive approach to lung function in bronchiectasis 71
Treatable traits in interstitial lung diseases: a call to action 70
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 70
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 70
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 69
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 69
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults 68
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 66
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 66
Cardiovascular side-effects of common antibiotics 66
Post-COVID-19 sequelae 66
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group 66
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 65
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 65
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 64
What is the best technique to extract bacterial DNA from sputum? 64
COVID-19 multidisciplinary high dependency unit: the Milan model 63
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsA case series on the use of Nuclear Medicine in NTM-PD 63
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 62
Comparison of different conditions for DNA extraction in sputum - a pilot study 62
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 62
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 62
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 62
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 62
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 61
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 61
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 61
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet 61
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 61
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 60
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study 60
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 59
O papel da neutropenia no prognóstico do doente oncológico com pneumonia adquirida na comunidade = The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 58
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia 58
A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP 58
Antibiotics for lung disease and cancer 58
How to Identify Causes and Predisposing Factors in Bronchiectasis 57
Respiratory failure in COVID-19: a patient's perspective and clinical cases 57
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia 57
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 57
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis 56
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 56
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 55
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 54
Long-Term Outcomes in Severe Community-Acquired Pneumonia 54
Neutrophil elastase in bronchiectasis 54
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 54
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC) 54
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 54
Site of care and multidisciplinary approach 54
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 54
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 54
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 54
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials 53
Lung Ultrasound in the Diagnosis and Follow-up of Community-Acquired Pneumonia : A Prospective, Multicenter, Diagnostic Accuracy Study 53
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 52
Williams-Campbell Syndrome Case Series and Discordant Twins 52
Detection and Classification of Bronchiectasis Through Convolutional Neural Networks 52
Reassessing the Landscape of Viral Respiratory Infections After the COVID-19 Pandemic 52
Empirical Coverage of Methicillin-Resistant Staphylococcus aureus in Community-Acquired Pneumonia : Those Who Do Not Remember the Past Are Doomed to Repeat It 52
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 52
The Relationship Between Symptoms, Exacerbations and Treatment Response in Bronchiectasis 51
A worldwide look into long COVID-19 management: an END-COVID survey 51
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis 51
Mixed Community-acquired Lower Respiratory Tract Infections 50
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 50
Protease-Antiprotease Imbalance in Bronchiectasis 50
Pneumonia: how important are local epidemiology and smoking habits? 50
Bacteremic pneumococcal pneumonia : clinical outcomes and preliminary results of inflammatory response 50
Bronchiectasis and Aspergillus: how are they linked? 50
Quinine treatment in severe Plasmodium falciparum malaria in children. A Holter monitoring 50
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 50
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 49
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 49
Treatment in exacerbations of the upper and lower airways 49
Life-threatening complications in ophthalmic surgery: a systematic review 49
Low Salivary Secretory Leukocyte Protease Inhibitor Levels Are Related to Airway Pseudomonas aeruginosa Infection in Bronchiectasis 48
Chlamydia pneumoniae and Mycoplasma pneumoniae 48
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis 48
Totale 7.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 2 1 4
2021/202260 0 1 2 4 0 0 0 3 8 20 17 5
2022/2023595 25 8 19 9 16 5 55 14 43 65 322 14
2023/20243.347 221 157 794 191 171 607 220 92 39 143 295 417
2024/20254.305 119 23 40 88 100 515 237 236 938 1.117 455 437
2025/202611.263 1.773 857 1.264 956 432 686 3.569 576 620 530 0 0
Totale 19.614